temozolomide has been researched along with 6-[(3-aminophenyl)methyl]-4-methyl-2-methylsulfinyl-5-thieno[3,4]pyrrolo[1,3-d]pyridazinone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Ding, Y; Ge, W; Guo, H; Hao, X; Hu, K; Li, A; Li, J; Li, Y; Liu, S; Wang, D; Wang, T; Xue, Q; Zhang, Q; Zhang, Y | 1 |
1 other study(ies) available for temozolomide and 6-[(3-aminophenyl)methyl]-4-methyl-2-methylsulfinyl-5-thieno[3,4]pyrrolo[1,3-d]pyridazinone
| Article | Year |
|---|---|
Identification of Parthenolide Dimers as Activators of Pyruvate Kinase M2 in Xenografts of Glioblastoma Multiforme in Vivo.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Glioblastoma; Humans; Prodrugs; Protein Kinase Inhibitors; Pyruvate Kinase; Sesquiterpenes; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2020 |